课题基金 / 基金详情

Mechanisms and biological consequences of the nuclear receptor CAR activation

Mechanisms and biological consequences of the nuclear receptor CAR activation
核受体 CAR 激活的机制和生物学后果
批准号:
10004464
负责人:
MASAHIKO NEGISHI
金额:
$262.09万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

MASAHIKO NEGISHI的其他基金

相似基金

相关文献

中文摘要
翻译
CAR和PXR是核受体超家族中NR1I亚家族的成员。我的实验室是第一个将CAR描述为药物激活的核受体的实验室,领导了世界范围内对CAR和PXR的研究,并确定了它们的生物学作用。CAR和PXR不仅调节肝脏药物代谢和处置,还调节糖异生、脂肪生成和生酮等能量代谢。此外,它们还调节细胞生长和死亡信号,包括JNK1、p38MAPK、AKT和GADD45信号。因此,CAR和PXR现在与各种肝脏毒性和肝脏肿瘤等疾病有关。现在已经知道这些受体在这些调控中作为转录因子和信号转导。然而,它们的分子机制目前还不完全清楚。我们的研究发现,CAR在DBD中的苏氨酸38位点被磷酸化并失活。这种磷酸化是CAR功能分化的基本原理。例如,苯巴比妥通过结合EGF受体和/或胰岛素受体并抑制其下游ERK1/2信号,通过蛋白磷酸酶2A刺激苏氨酸38的去磷酸化,从而激活CAR。在PXR中,LBD中丝氨酸350的磷酸化调节其功能。这些磷酸化基序在大多数核受体中是保守的,这表明CAR和PXR的发现可能涉及许多其他核受体的研究
英文摘要
CAR and PXR are members of the NR1I subfamily within the nuclear receptor superfamily. My laboratory was the first to characterize CAR as a drug-activated nuclear receptor, leading world-wide investigations to characterize CAR and PXR and establish their biological roles. Both CAR and PXR regulate not only hepatic drug metabolism and disposition but also energy metabolism such as gluconeogenesis and lipogenesis and ketogenesis. In addition, they regulate cell growth and death signals as well, which includes JNK1, p38MAPK, AKT and GADD45 signals. Consequently, CAR and PXR have now been implicated in various hepatic toxicities and diseases such as liver tumors. It is now known that these receptors act as transcription factors as well as signal transducers in these regulations. However, their molecular mechanisms are not fully understood now. Our work found that CAR is phosphorylated at threonine 38 within the DBD and is inactivated. This phosphorylation is the underlying principle through which CAR functions diverge. For example, phenobarbital stimulates dephosphorization of threonine 38 by protein phosphatase 2A, by binding EGF receptor and/or insulin receptor and repressing their down-stream ERK1/2 signal for CAR activation. In PXR, phosphorylation of serine 350 within the LBD regulates its functions. These phosphorylation motifs within the DBD or LBD are conserved in the majority of nuclear receptors, suggesting that findings with CAR and PXR can be implicated in the investigations of numerous other nuclear receptors Estrogen receptor (ER) conserves threonine 38 of CAR at serine 216 within its DBD. With a phospho-Ser216peptide antibody, it was found that ER is specifically phosphorylated at serine 216 in immune cells such as neutrophils and macrophages in mice. ER KI (Esr1S216A) mice bearing a non-phosphomimetic alanine mutation were generated to investigate the biological roles of this phosphorylation. ER KI mice are fertile but develop obesity. Analysis of brains and microglia and Kupffer cells (resident macrophages in the brain or liver) showed that this phosphorylation confers anti-inflammatory and anti-apoptotic capabilities to ER Phosphorylated ER can be a novel target to investigate various diseases such as obesity and inflammation-related neurodegenerative diseases and their mechanisms. ER KI mice can be an excellent animal model for these investigations. Retinoid related orphan receptor (ROR) conserves this phosphorylation at serine 100 within the DBD. This serine residue becomes phosphorylated in mouse livers in response to phenobarbital treatment, regulating CAR-targeted genes. These nuclear receptors appears to communicate through the conserved phosphorylation, regulating genes and disease developments in response to environmental chemicals and providing an excellent experimental system to investigate the molecular mechanism of this communication. in response to drug treatments and/or physiological/pathophysiological conditions. There are 40 nuclear receptors which conserve this motif with the DBD, enabling us to extend the same line of communication study far beyond these three nuclear receptors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms and biological consequences of the nuclear receptor CAR activation
Mechanisms and biological consequences of the nuclear receptor CAR activation
Mechanism and biological consequences of the nuclear rec
Pharmacogenetics Of Microsomal Steroid Hydroxylases
海外基金